ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Eflornithine Drugs Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-0K18778
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Eflornithine Drugs Market Research Report 2024
BUY CHAPTERS

Global Eflornithine Drugs Market Research Report 2024

Code: QYRE-Auto-0K18778
Report
October 2024
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Almirall
US WorldMeds
Cipher Pharmaceuticals
Allergan plc
Actiza Pharmaceutical
Lotus International
Incepta Pharmaceuticals
Sun Pharma
Derma Pella Pharmaceuticals
SkinMedica Pharmaceuticals
Kavya pharm

Eflornithine Drugs Market

Eflornithine is a drug that acts as a selective irreversible inhibitor of the enzyme ornithine decarboxylase, which is crucial for cell growth and proliferation. It is primarily used in the form of a topical cream for managing unwanted facial hair in women, where it slows down hair growth by disrupting the normal hair follicle cycle. Additionally, eflornithine is also used in an oral form as a treatment for African sleeping sickness caused by Trypanosoma brucei gambiense.
The global Eflornithine Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Eflornithine, initially developed for its potential as an anti-cancer agent due to its inhibition of ornithine decarboxylase, saw a shift in its primary use when researchers discovered its efficacy in treating African sleeping sickness, or human African trypanosomiasis, caused by Trypanosoma brucei gambiense. Its development as a treatment for this parasitic disease marked a significant milestone in addressing a neglected tropical illness. The drug was approved for this indication by the U.S. FDA in 2000 and the European Medicines Agency in 2001, highlighting its importance in the fight against a serious health issue affecting impoverished regions.
The application of eflornithine extended beyond tropical disease when it was later repurposed for dermatological use. In the early 2000s, it was recognized for its potential to reduce unwanted facial hair in women, leading to the development of a topical formulation marketed as Vaniqa. This repurposing demonstrated the drug's versatility and expanded its market, offering a solution for patients dealing with excessive facial hair growth due to conditions like hirsutism. The approval of Vaniqa by the FDA in 2009 underscored the innovative use of eflornithine beyond its initial therapeutic scope.
The development trend for eflornithine reflects a broader pattern of drug repurposing, where existing medications are evaluated for new therapeutic uses. This approach not only maximizes the utility of existing drugs but also potentially reduces the time and cost associated with developing entirely new treatments. The ongoing research into eflornithine's mechanisms and its potential applications in other areas of medicine could further enhance its therapeutic impact and contribute to more targeted and effective treatments for a variety of conditions.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Eflornithine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eflornithine Drugs.
The Eflornithine Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Eflornithine Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eflornithine Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Eflornithine Drugs Market Report

Report Metric Details
Report Name Eflornithine Drugs Market
Segment by Type
  • Tablets
  • Injection
  • Topical Cream
Segment by Application
  • Neuroblastoma
  • African trypanosomiasis
  • Hirsutism
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bristol Myers Squibb, Derma Pella Pharmaceuticals, Almirall, US WorldMeds, Cipher Pharmaceuticals, Allergan, SkinMedica Pharmaceuticals, Actiza Pharmaceutical, Lotus International, Incepta Pharmaceuticals, Sun Pharma, Kavya pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Eflornithine Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Eflornithine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Eflornithine Drugs Market report?

Ans: The main players in the Eflornithine Drugs Market are Bristol Myers Squibb, Derma Pella Pharmaceuticals, Almirall, US WorldMeds, Cipher Pharmaceuticals, Allergan, SkinMedica Pharmaceuticals, Actiza Pharmaceutical, Lotus International, Incepta Pharmaceuticals, Sun Pharma, Kavya pharm

What are the Application segmentation covered in the Eflornithine Drugs Market report?

Ans: The Applications covered in the Eflornithine Drugs Market report are Neuroblastoma, African trypanosomiasis, Hirsutism, Others

What are the Type segmentation covered in the Eflornithine Drugs Market report?

Ans: The Types covered in the Eflornithine Drugs Market report are Tablets, Injection, Topical Cream

1 Eflornithine Drugs Market Overview
1.1 Product Definition
1.2 Eflornithine Drugs by Type
1.2.1 Global Eflornithine Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Injection
1.2.4 Topical Cream
1.3 Eflornithine Drugs by Application
1.3.1 Global Eflornithine Drugs Market Value by Application (2024-2030)
1.3.2 Neuroblastoma
1.3.3 African trypanosomiasis
1.3.4 Hirsutism
1.3.5 Others
1.4 Global Eflornithine Drugs Market Size Estimates and Forecasts
1.4.1 Global Eflornithine Drugs Revenue 2019-2030
1.4.2 Global Eflornithine Drugs Sales 2019-2030
1.4.3 Global Eflornithine Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Eflornithine Drugs Market Competition by Manufacturers
2.1 Global Eflornithine Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Eflornithine Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Eflornithine Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Eflornithine Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eflornithine Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eflornithine Drugs, Product Type & Application
2.7 Global Key Manufacturers of Eflornithine Drugs, Date of Enter into This Industry
2.8 Global Eflornithine Drugs Market Competitive Situation and Trends
2.8.1 Global Eflornithine Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Eflornithine Drugs Players Market Share by Revenue
2.8.3 Global Eflornithine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Eflornithine Drugs Market Scenario by Region
3.1 Global Eflornithine Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Eflornithine Drugs Sales by Region: 2019-2030
3.2.1 Global Eflornithine Drugs Sales by Region: 2019-2024
3.2.2 Global Eflornithine Drugs Sales by Region: 2025-2030
3.3 Global Eflornithine Drugs Revenue by Region: 2019-2030
3.3.1 Global Eflornithine Drugs Revenue by Region: 2019-2024
3.3.2 Global Eflornithine Drugs Revenue by Region: 2025-2030
3.4 North America Eflornithine Drugs Market Facts & Figures by Country
3.4.1 North America Eflornithine Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Eflornithine Drugs Sales by Country (2019-2030)
3.4.3 North America Eflornithine Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eflornithine Drugs Market Facts & Figures by Country
3.5.1 Europe Eflornithine Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Eflornithine Drugs Sales by Country (2019-2030)
3.5.3 Europe Eflornithine Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eflornithine Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Eflornithine Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Eflornithine Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Eflornithine Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Eflornithine Drugs Market Facts & Figures by Country
3.7.1 Latin America Eflornithine Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Eflornithine Drugs Sales by Country (2019-2030)
3.7.3 Latin America Eflornithine Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Eflornithine Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Eflornithine Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Eflornithine Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Eflornithine Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eflornithine Drugs Sales by Type (2019-2030)
4.1.1 Global Eflornithine Drugs Sales by Type (2019-2024)
4.1.2 Global Eflornithine Drugs Sales by Type (2025-2030)
4.1.3 Global Eflornithine Drugs Sales Market Share by Type (2019-2030)
4.2 Global Eflornithine Drugs Revenue by Type (2019-2030)
4.2.1 Global Eflornithine Drugs Revenue by Type (2019-2024)
4.2.2 Global Eflornithine Drugs Revenue by Type (2025-2030)
4.2.3 Global Eflornithine Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Eflornithine Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Eflornithine Drugs Sales by Application (2019-2030)
5.1.1 Global Eflornithine Drugs Sales by Application (2019-2024)
5.1.2 Global Eflornithine Drugs Sales by Application (2025-2030)
5.1.3 Global Eflornithine Drugs Sales Market Share by Application (2019-2030)
5.2 Global Eflornithine Drugs Revenue by Application (2019-2030)
5.2.1 Global Eflornithine Drugs Revenue by Application (2019-2024)
5.2.2 Global Eflornithine Drugs Revenue by Application (2025-2030)
5.2.3 Global Eflornithine Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Eflornithine Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Company Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol Myers Squibb Eflornithine Drugs Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Derma Pella Pharmaceuticals
6.2.1 Derma Pella Pharmaceuticals Company Information
6.2.2 Derma Pella Pharmaceuticals Description and Business Overview
6.2.3 Derma Pella Pharmaceuticals Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Derma Pella Pharmaceuticals Eflornithine Drugs Product Portfolio
6.2.5 Derma Pella Pharmaceuticals Recent Developments/Updates
6.3 Almirall
6.3.1 Almirall Company Information
6.3.2 Almirall Description and Business Overview
6.3.3 Almirall Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Almirall Eflornithine Drugs Product Portfolio
6.3.5 Almirall Recent Developments/Updates
6.4 US WorldMeds
6.4.1 US WorldMeds Company Information
6.4.2 US WorldMeds Description and Business Overview
6.4.3 US WorldMeds Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 US WorldMeds Eflornithine Drugs Product Portfolio
6.4.5 US WorldMeds Recent Developments/Updates
6.5 Cipher Pharmaceuticals
6.5.1 Cipher Pharmaceuticals Company Information
6.5.2 Cipher Pharmaceuticals Description and Business Overview
6.5.3 Cipher Pharmaceuticals Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipher Pharmaceuticals Eflornithine Drugs Product Portfolio
6.5.5 Cipher Pharmaceuticals Recent Developments/Updates
6.6 Allergan
6.6.1 Allergan Company Information
6.6.2 Allergan Description and Business Overview
6.6.3 Allergan Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Allergan Eflornithine Drugs Product Portfolio
6.6.5 Allergan Recent Developments/Updates
6.7 SkinMedica Pharmaceuticals
6.7.1 SkinMedica Pharmaceuticals Company Information
6.7.2 SkinMedica Pharmaceuticals Description and Business Overview
6.7.3 SkinMedica Pharmaceuticals Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 SkinMedica Pharmaceuticals Eflornithine Drugs Product Portfolio
6.7.5 SkinMedica Pharmaceuticals Recent Developments/Updates
6.8 Actiza Pharmaceutical
6.8.1 Actiza Pharmaceutical Company Information
6.8.2 Actiza Pharmaceutical Description and Business Overview
6.8.3 Actiza Pharmaceutical Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Actiza Pharmaceutical Eflornithine Drugs Product Portfolio
6.8.5 Actiza Pharmaceutical Recent Developments/Updates
6.9 Lotus International
6.9.1 Lotus International Company Information
6.9.2 Lotus International Description and Business Overview
6.9.3 Lotus International Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lotus International Eflornithine Drugs Product Portfolio
6.9.5 Lotus International Recent Developments/Updates
6.10 Incepta Pharmaceuticals
6.10.1 Incepta Pharmaceuticals Company Information
6.10.2 Incepta Pharmaceuticals Description and Business Overview
6.10.3 Incepta Pharmaceuticals Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Incepta Pharmaceuticals Eflornithine Drugs Product Portfolio
6.10.5 Incepta Pharmaceuticals Recent Developments/Updates
6.11 Sun Pharma
6.11.1 Sun Pharma Company Information
6.11.2 Sun Pharma Description and Business Overview
6.11.3 Sun Pharma Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Pharma Eflornithine Drugs Product Portfolio
6.11.5 Sun Pharma Recent Developments/Updates
6.12 Kavya pharm
6.12.1 Kavya pharm Company Information
6.12.2 Kavya pharm Description and Business Overview
6.12.3 Kavya pharm Eflornithine Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kavya pharm Eflornithine Drugs Product Portfolio
6.12.5 Kavya pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eflornithine Drugs Industry Chain Analysis
7.2 Eflornithine Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eflornithine Drugs Production Mode & Process
7.4 Eflornithine Drugs Sales and Marketing
7.4.1 Eflornithine Drugs Sales Channels
7.4.2 Eflornithine Drugs Distributors
7.5 Eflornithine Drugs Customers
8 Eflornithine Drugs Market Dynamics
8.1 Eflornithine Drugs Industry Trends
8.2 Eflornithine Drugs Market Drivers
8.3 Eflornithine Drugs Market Challenges
8.4 Eflornithine Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Almirall
US WorldMeds
Cipher Pharmaceuticals
Allergan plc
Actiza Pharmaceutical
Lotus International
Incepta Pharmaceuticals
Sun Pharma
Derma Pella Pharmaceuticals
SkinMedica Pharmaceuticals
Kavya pharm
List of Tables
 Table 1. Global Eflornithine Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Eflornithine Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Eflornithine Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Eflornithine Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Eflornithine Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Eflornithine Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Eflornithine Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Eflornithine Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Eflornithine Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Eflornithine Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Eflornithine Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Eflornithine Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Eflornithine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eflornithine Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Eflornithine Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Eflornithine Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Eflornithine Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Eflornithine Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Eflornithine Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Eflornithine Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Eflornithine Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Eflornithine Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Eflornithine Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Eflornithine Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Eflornithine Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Eflornithine Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Eflornithine Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Eflornithine Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Eflornithine Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Eflornithine Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Eflornithine Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Eflornithine Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Eflornithine Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Eflornithine Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Eflornithine Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Eflornithine Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Eflornithine Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Eflornithine Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Eflornithine Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Eflornithine Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Eflornithine Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Eflornithine Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Eflornithine Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Eflornithine Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Eflornithine Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Eflornithine Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Eflornithine Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Eflornithine Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Eflornithine Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Eflornithine Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Eflornithine Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Eflornithine Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Eflornithine Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Eflornithine Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Eflornithine Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Eflornithine Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Eflornithine Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Eflornithine Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Eflornithine Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Eflornithine Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Eflornithine Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Eflornithine Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Eflornithine Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Eflornithine Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Eflornithine Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Eflornithine Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Eflornithine Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Eflornithine Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Bristol Myers Squibb Company Information
 Table 71. Bristol Myers Squibb Description and Business Overview
 Table 72. Bristol Myers Squibb Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Bristol Myers Squibb Eflornithine Drugs Product
 Table 74. Bristol Myers Squibb Recent Developments/Updates
 Table 75. Derma Pella Pharmaceuticals Company Information
 Table 76. Derma Pella Pharmaceuticals Description and Business Overview
 Table 77. Derma Pella Pharmaceuticals Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Derma Pella Pharmaceuticals Eflornithine Drugs Product
 Table 79. Derma Pella Pharmaceuticals Recent Developments/Updates
 Table 80. Almirall Company Information
 Table 81. Almirall Description and Business Overview
 Table 82. Almirall Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Almirall Eflornithine Drugs Product
 Table 84. Almirall Recent Developments/Updates
 Table 85. US WorldMeds Company Information
 Table 86. US WorldMeds Description and Business Overview
 Table 87. US WorldMeds Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. US WorldMeds Eflornithine Drugs Product
 Table 89. US WorldMeds Recent Developments/Updates
 Table 90. Cipher Pharmaceuticals Company Information
 Table 91. Cipher Pharmaceuticals Description and Business Overview
 Table 92. Cipher Pharmaceuticals Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Cipher Pharmaceuticals Eflornithine Drugs Product
 Table 94. Cipher Pharmaceuticals Recent Developments/Updates
 Table 95. Allergan Company Information
 Table 96. Allergan Description and Business Overview
 Table 97. Allergan Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Allergan Eflornithine Drugs Product
 Table 99. Allergan Recent Developments/Updates
 Table 100. SkinMedica Pharmaceuticals Company Information
 Table 101. SkinMedica Pharmaceuticals Description and Business Overview
 Table 102. SkinMedica Pharmaceuticals Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. SkinMedica Pharmaceuticals Eflornithine Drugs Product
 Table 104. SkinMedica Pharmaceuticals Recent Developments/Updates
 Table 105. Actiza Pharmaceutical Company Information
 Table 106. Actiza Pharmaceutical Description and Business Overview
 Table 107. Actiza Pharmaceutical Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Actiza Pharmaceutical Eflornithine Drugs Product
 Table 109. Actiza Pharmaceutical Recent Developments/Updates
 Table 110. Lotus International Company Information
 Table 111. Lotus International Description and Business Overview
 Table 112. Lotus International Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Lotus International Eflornithine Drugs Product
 Table 114. Lotus International Recent Developments/Updates
 Table 115. Incepta Pharmaceuticals Company Information
 Table 116. Incepta Pharmaceuticals Description and Business Overview
 Table 117. Incepta Pharmaceuticals Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Incepta Pharmaceuticals Eflornithine Drugs Product
 Table 119. Incepta Pharmaceuticals Recent Developments/Updates
 Table 120. Sun Pharma Company Information
 Table 121. Sun Pharma Description and Business Overview
 Table 122. Sun Pharma Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Sun Pharma Eflornithine Drugs Product
 Table 124. Sun Pharma Recent Developments/Updates
 Table 125. Kavya pharm Company Information
 Table 126. Kavya pharm Description and Business Overview
 Table 127. Kavya pharm Eflornithine Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Kavya pharm Eflornithine Drugs Product
 Table 129. Kavya pharm Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Eflornithine Drugs Distributors List
 Table 133. Eflornithine Drugs Customers List
 Table 134. Eflornithine Drugs Market Trends
 Table 135. Eflornithine Drugs Market Drivers
 Table 136. Eflornithine Drugs Market Challenges
 Table 137. Eflornithine Drugs Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Eflornithine Drugs
 Figure 2. Global Eflornithine Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Eflornithine Drugs Market Share by Type: 2023 & 2030
 Figure 4. Tablets Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Topical Cream Product Picture
 Figure 7. Global Eflornithine Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Eflornithine Drugs Market Share by Application: 2023 & 2030
 Figure 9. Neuroblastoma
 Figure 10. African trypanosomiasis
 Figure 11. Hirsutism
 Figure 12. Others
 Figure 13. Global Eflornithine Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Eflornithine Drugs Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Eflornithine Drugs Sales (2019-2030) & (K Units)
 Figure 16. Global Eflornithine Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 17. Eflornithine Drugs Report Years Considered
 Figure 18. Eflornithine Drugs Sales Share by Manufacturers in 2023
 Figure 19. Global Eflornithine Drugs Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Eflornithine Drugs Players: Market Share by Revenue in Eflornithine Drugs in 2023
 Figure 21. Eflornithine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Eflornithine Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Eflornithine Drugs Sales Market Share by Country (2019-2030)
 Figure 24. North America Eflornithine Drugs Revenue Market Share by Country (2019-2030)
 Figure 25. United States Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Eflornithine Drugs Sales Market Share by Country (2019-2030)
 Figure 28. Europe Eflornithine Drugs Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Eflornithine Drugs Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Eflornithine Drugs Revenue Market Share by Region (2019-2030)
 Figure 36. China Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Eflornithine Drugs Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Eflornithine Drugs Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Eflornithine Drugs Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Eflornithine Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Eflornithine Drugs by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Eflornithine Drugs by Type (2019-2030)
 Figure 55. Global Eflornithine Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Eflornithine Drugs by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Eflornithine Drugs by Application (2019-2030)
 Figure 58. Global Eflornithine Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 59. Eflornithine Drugs Value Chain
 Figure 60. Eflornithine Drugs Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Drugs to Treat Hypertriglyceridemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37P13132
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Medications for Canine Atopic Dermatitis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-13T13744
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Medications for Actinic Keratosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-36R13742
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Melatonin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-21J13714
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions